ADAR1 Capital Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Buy
404,497
+30,000
+8% +$41.3K 0.02% 207
2026
Q1
$483K Buy
374,497
+19,087
+5% +$31.5K 0.03% 204
2025
Q4
$785K Buy
355,410
+140,913
+66% +$265K 0.06% 152
2025
Q3
$347K Buy
214,497
+10,000
+5% +$20.9K 0.03% 158
2025
Q2
$530K Buy
+204,497
New +$807K 0.08% 113
2025
Q1
Sell
-28,221
Closed -$192K 235
2024
Q4
$192K Buy
+28,221
New +$186K 0.04% 157

Other funds holding LUNG

ADAR1 Capital Management's LUNG Position: Q2 2026 in Review

ADAR1 Capital Management increased its Pulmonx (LUNG) stake by 8% in Q2 2026, buying an estimated $41.3K and bringing the position to 404,497 shares worth $526K. The position accounts for 0.02% of the portfolio, ranked #207.

ADAR1 Capital Management first reported a position in LUNG in Q4 2024 and has held it in 6 quarters since. The position peaked at $785K in Q4 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • ADAR1 Capital Management held 404,497 shares of Pulmonx worth $526K as of Q2 2026.
  • ADAR1 Capital Management bought 30,000 Pulmonx shares in Q2 2026, an estimated $41.3K.
  • Pulmonx made up 0.02% of ADAR1 Capital Management's portfolio in Q2 2026, its #207 holding.
  • ADAR1 Capital Management first reported a position in Pulmonx in Q4 2024 and has held it in 6 quarters since.
  • ADAR1 Capital Management's Pulmonx position peaked at $785K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.